Triskelion@slideshare
•
3 likes•504 views
Triskelion changed its name and logo in March 2016. It is a contract research organization located in the Netherlands with 220 employees. It focuses on toxicology, analytical services, regulatory services, risk evaluation, ADME/DMPK, pharmacology, and immunology. Within immunology, Triskelion studies autoimmune diseases, cancer immunotherapy, viral infections, and more using both in vitro and in vivo models like humanized mouse models. For more information, contact Paul Stoffels.
Report
Share
Report
Share
Download to read offline
Recommended
Tno productblad infectious diseases_web
TNO Triskelion BSL-3 lab tests anti-viral drugs in newly developed H7N9 influenza model
Human infections with a new avian influenza A (H7N9) virus were first reported in China in 2013, with the loss of 46 lives. In order to meet the growing needs to test new drugs against H7N9, TNO Triskelion has recently developed an H7N9 mouse model. This H7N9 model is suitable for testing new anti-virals such as vaccines, monoclonal antibodies and small molecules in our BSL-3 lab, in conformity with Good Laboratory Practice. TNO Triskelion has proven to be a successful partner in the development of new anti-viral and anti-bacterial vaccines for many years. Understanding the pressures on time lines, we support companies and institutes during the preclinical and clinical stages of drug development.
Skim Fieldwork Division Profile
SKIM Fieldwork is an independent high-quality service-based
fieldwork agency, part of SKIM group (1979).
SKIM Fieldwork has a strong reputation for being pro-active and
helping agencies as yourselves to plan and conduct their medical market research in the Netherlands.
Crb Bio Ii Summary Nov2010 Eng
This document introduces a new €60 million venture capital fund called CRB Bio II that will invest in early-stage biotech companies. It will be managed by CRB Inverbío, a new venture capital firm created by the founding partners of Cross Road Biotech, a Spanish VC firm with experience investing in 11 biotech companies. The fund aims to generate high returns by leveraging the management team's expertise and network in the biotech industry in Spain.
CTSC 16
This document summarizes a clinical trials supply chain congress taking place from April 11-12, 2016 in London. It will feature presentations and panel discussions on optimizing the clinical trials supply chain process with key stakeholders from pharmaceutical companies such as Sanofi, Roche, and Takeda. Speakers will discuss strategies to improve supply chain planning, regulatory compliance, and risk management. The event aims to provide a platform for the pharmaceutical industry to address challenges in navigating the complex clinical trials supply landscape.
Clinical Trial Supply
This document provides information about the "Clinical Trials Supply Chain Global Congress 2016 Europe" conference which will take place from Monday to Tuesday, April 11-12, 2016 at the Hilton London Kensington Hotel in London, UK. The conference will discuss navigating the clinical trials supply chain landscape and feature presentations from key stakeholders in clinical trials supply from companies like Sanofi, Roche, Pfizer and Boehringer Ingelheim. It will also cover topics like the influence of clinical trial supply on planning processes, coordinating projects efficiently, new EU clinical trial regulations, and maintaining quality in storage and distribution.
Turacoz corporate profile updated 2019
Turacoz Healthcare Solutions is an ISO certified medical communications company that provides services across scientific communication, clinical trials, regulatory support, and training. It has over 120 employees serving 35 pharmaceutical clients and 82 research institutes globally. The presentation provides details on Turacoz's services, experience, clients, and team to promote the company's capabilities in supporting all stages of product development and regulatory processes.
Turacoz corporate profile updated 2019
Turacoz Healthcare Solutions is an ISO certified medical communications company that provides services across scientific communication, clinical trials, regulatory support, and training. It has over 120 employees serving 35 pharmaceutical clients and 82 research institutes globally. The presentation provides details on Turacoz's services, experience, clients, and team to promote the company's capabilities in supporting all stages of product development and regulatory processes.
SMi Group's 12th annual Asthma and COPD 2016 conference
This document announces a two-day conference on asthma and COPD taking place on April 11-12, 2016 in London. The conference will discuss challenges in developing treatments for these conditions, including new inhaled drugs and generic inhalation products. Speakers will address topics such as corticosteroid insensitivity in severe asthma, identification and prevention of COPD exacerbations, and challenges in developing drugs and devices. Two optional half-day workshops on April 13 will focus on human factors in inhaler handling studies and pragmatic compliance remediation for marketed products.
Recommended
Tno productblad infectious diseases_web
TNO Triskelion BSL-3 lab tests anti-viral drugs in newly developed H7N9 influenza model
Human infections with a new avian influenza A (H7N9) virus were first reported in China in 2013, with the loss of 46 lives. In order to meet the growing needs to test new drugs against H7N9, TNO Triskelion has recently developed an H7N9 mouse model. This H7N9 model is suitable for testing new anti-virals such as vaccines, monoclonal antibodies and small molecules in our BSL-3 lab, in conformity with Good Laboratory Practice. TNO Triskelion has proven to be a successful partner in the development of new anti-viral and anti-bacterial vaccines for many years. Understanding the pressures on time lines, we support companies and institutes during the preclinical and clinical stages of drug development.
Skim Fieldwork Division Profile
SKIM Fieldwork is an independent high-quality service-based
fieldwork agency, part of SKIM group (1979).
SKIM Fieldwork has a strong reputation for being pro-active and
helping agencies as yourselves to plan and conduct their medical market research in the Netherlands.
Crb Bio Ii Summary Nov2010 Eng
This document introduces a new €60 million venture capital fund called CRB Bio II that will invest in early-stage biotech companies. It will be managed by CRB Inverbío, a new venture capital firm created by the founding partners of Cross Road Biotech, a Spanish VC firm with experience investing in 11 biotech companies. The fund aims to generate high returns by leveraging the management team's expertise and network in the biotech industry in Spain.
CTSC 16
This document summarizes a clinical trials supply chain congress taking place from April 11-12, 2016 in London. It will feature presentations and panel discussions on optimizing the clinical trials supply chain process with key stakeholders from pharmaceutical companies such as Sanofi, Roche, and Takeda. Speakers will discuss strategies to improve supply chain planning, regulatory compliance, and risk management. The event aims to provide a platform for the pharmaceutical industry to address challenges in navigating the complex clinical trials supply landscape.
Clinical Trial Supply
This document provides information about the "Clinical Trials Supply Chain Global Congress 2016 Europe" conference which will take place from Monday to Tuesday, April 11-12, 2016 at the Hilton London Kensington Hotel in London, UK. The conference will discuss navigating the clinical trials supply chain landscape and feature presentations from key stakeholders in clinical trials supply from companies like Sanofi, Roche, Pfizer and Boehringer Ingelheim. It will also cover topics like the influence of clinical trial supply on planning processes, coordinating projects efficiently, new EU clinical trial regulations, and maintaining quality in storage and distribution.
Turacoz corporate profile updated 2019
Turacoz Healthcare Solutions is an ISO certified medical communications company that provides services across scientific communication, clinical trials, regulatory support, and training. It has over 120 employees serving 35 pharmaceutical clients and 82 research institutes globally. The presentation provides details on Turacoz's services, experience, clients, and team to promote the company's capabilities in supporting all stages of product development and regulatory processes.
Turacoz corporate profile updated 2019
Turacoz Healthcare Solutions is an ISO certified medical communications company that provides services across scientific communication, clinical trials, regulatory support, and training. It has over 120 employees serving 35 pharmaceutical clients and 82 research institutes globally. The presentation provides details on Turacoz's services, experience, clients, and team to promote the company's capabilities in supporting all stages of product development and regulatory processes.
SMi Group's 12th annual Asthma and COPD 2016 conference
This document announces a two-day conference on asthma and COPD taking place on April 11-12, 2016 in London. The conference will discuss challenges in developing treatments for these conditions, including new inhaled drugs and generic inhalation products. Speakers will address topics such as corticosteroid insensitivity in severe asthma, identification and prevention of COPD exacerbations, and challenges in developing drugs and devices. Two optional half-day workshops on April 13 will focus on human factors in inhaler handling studies and pragmatic compliance remediation for marketed products.
P 135 asthma and copd
This document provides information about an upcoming conference on asthma and COPD to be held on April 13-14, 2015 in London. It lists key speakers from academic institutions and pharmaceutical companies that will discuss topics such as new therapeutics, personalised treatment approaches, viral exacerbations, and biomarkers. An interactive workshop on functional respiratory imaging is also advertised to take place on April 15. The document provides an agenda with session details and encourages registration by certain dates to receive discounts.
SMi Group's RNA Therapeutics 2019 conference
This document provides information about the 10th Annual Conference on RNA Therapeutics taking place on February 20-21, 2019 in London. It outlines the chairs, guest speakers, and key speakers at the conference, as well as featured highlights and topics to be discussed. Some of the topics to be covered include the clinical progress of spherical nucleic acids with Exicure, Sanofi's strategies for oligonucleotide delivery, ProQR's plans for oligonucleotide supply, and the development of self-amplifying mRNA vaccines at GSK. The document provides an agenda and schedule for the two-day conference.
SMi Group's Superbugs & Superdrugs 2016 conference
This document provides information on two pre-conference workshops at the "Superbugs & Superdrugs" conference on combating antimicrobial resistance.
The first workshop discusses rapid diagnostic tools for infectious diseases, focusing on tracking emerging infections, state-of-the-art diagnostic methods, mobile applications, and challenges in diagnosis.
The second workshop examines how antimicrobial copper touch surfaces can improve patient outcomes and reduce costs by lowering healthcare-associated infections and antimicrobial resistance. It will evaluate the evidence supporting copper's use and discuss cost-benefit analysis and practical implementation.
P-163 Superbugs & Superdrugs
This document provides information on two pre-conference workshops at the "Superbugs & Superdrugs" conference on combating antimicrobial resistance.
The first workshop discusses rapid diagnostic tools for infectious diseases, focusing on tracking emerging infections, state-of-the-art diagnostic methods, mobile applications, and challenges in diagnosis.
The second workshop examines making materials like copper touch surfaces in healthcare settings to improve patient outcomes and reduce costs by lowering infection rates and antimicrobial resistance. It will evaluate the evidence for copper's antimicrobial efficacy and cost-benefit analysis.
2015 03-11 Opening EATRIS Finland, Helsinki
View how to enable personalzied healthcare through integrated technolgies, with great challenges to bridge the innovation gaps in biomarkers.
Epistem holdings plc (ehp) product pipeline analysis
Companyprofilesandconferences.com glad to promote a new report on "Epistem Holdings Plc (EHP) - Product Pipeline Analysis" which is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products also provides key information about the company, its major products and brands.
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Onorach Clinical is a clinical research organization headquartered in Dundee, Scotland that manages clinical trials from Phase I-IV. It has locations also in Latvia and provides services to pharmaceutical and medical device companies of all sizes. Onorach focuses on innovative electronic solutions to improve clinical trial quality and efficiency. It has expertise across many therapeutic areas including oncology, diabetes, vaccines, and more. Onorach aims to deliver high-quality, cost-effective clinical trial services through strategic partnerships.
2014 11-26 EATRIS biomarkers platform meeting, Amsterdam, Organising technolo...
Outlining the proces and lessons learned in organising the technological infrastructure at the Radboud university medical center, to shape the Radboudumc Technology Centers, supporting our mission in enabling personalized healthcare.
Europe's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdf
In this edition, 'Europe's Pioneering Leaders Shaping the Future of Healthcare - Edition 2', we explore the inspiring journeys of these remarkable individuals. From leveraging latest technologies to building collaboration among stakeholders, their initiatives are focused on improving patient outcomes and ensuring equitable access to healthcare services for all.
SMi Group's 8th annual COPD 2016 conference
This document advertises and provides information about the 8th Annual Conference on Chronic Obstructive Pulmonary Disease (COPD) to be held in London on October 19-20, 2016. It announces early registration discounts and details the conference agenda, speakers, and sessions on topics related to COPD drug development, treatment strategies, and predictive modeling. Attendees in 2015 represented pharmaceutical companies, consultancies, and academia from Europe, the UK, and the US. The conference organizers encourage sponsorship and exhibition opportunities to promote services and products to attendees.
Insights in Life Sciences (ilS) Provides Access to Global Life Sciences Experts
Insights in Life Sciences (ilS) provides guidance in project definition by ilS professionals; Life Sciences Expert screening via ilS platform (ilS NetworkSM); Telephone call scheduling via ilS NetworkSM; Telephone interviews and final reports (ilS ReportsSM) via ilS platform
SplunkLive! Stockholm 2017 - Norsk Helsenett Customer Presentation
Norsk Helsenett's customer presentation at SplunkLive! Stockholm, presented by Håkon Grimstad, CEO.
Attendees of SplunkLive! Stockholm learnt how more than 13,000 enterprises, government agencies, universities and service providers in over 110 countries use Splunk software to deepen business and customer understanding, mitigate cybersecurity risk, prevent fraud, improve service performance and reduce cost.
Become a Medicines Discovery Catapult Partner - Glasgow
We enable UK life science companies to develop their drug discovery projects. And through networks of expert labs and CROs our Virtual R&D team can access and provide:
> industrially rigorous advice in drug discovery
> clinical and commercial insight
> expertise in delivery and project management
If you are an SME with a drug discovery project, or a CRO with expertise to provide, attend this event and find out how we can help you.
ExL Pharma's European Medical Science Liaison Conference Brochure, October, L...
Scientific Advisors (SAs), Medical Advisors (MAs) and Medical Science Liaisons (MSLs) play a critical function within Medical Affairs departments of pharmaceutical, biotech and medical device companies. These typically highly educated and experienced professionals evaluate, critique and communicate comprehensive scientific information related to a company’s products. While differences in job titles, backgrounds and day-to-day activities can vary across companies and regions, MSLs and advisors are critical to improving understanding amongst internal departments and supporting product awareness across the broader medical community. They are credible peers on whom thought leaders can rely for current, objective and thorough information about disease states and treatments. They assist clinical teams, often support and help train the sales force, and develop relationships with key opinion leaders, among other activities. MSLs/Advisors are key players in the achievement of corporate business objectives in the fiercely competitive European marketplace.
ExL Pharma’s MSL Best Practices conference has a long and established history in the United States, with seven highly successful and valuable MSL events taking place throughout America over a five year period. These conferences continue to attract more and more industry professionals, and have solidified ExL Pharma as a leader in the provision of relevant and practical information for Medical Affairs professionals. From the US-based events, a need was assessed for a similar conference to take place in Europe. Thus, the European MSL & Medical/Scientific Advisor Best Practices conference was born.
We are excited to offer this unique opportunity in Europe for MSLs and Advisors throughout the industry to gather to share successful strategies for both field-based and office-based activities. Through the provision of case studies and educational presentations led by experienced industry professionals, ample networking time and interactive sessions, MSLs and Advisors are sure to gain take-home approaches for providing maximum value to key opinion leaders, the company and the industry as a whole.
We look forward to greeting you in London!
Cv Aloys Eng 2009
Since the early days of his career, he had strong conviction for holistic care en
innovation. Believing that the aim of society must be the self-fulfillment of each
individual, by promoting education at all levels.
Support for scientists and researchers, technology transfer, investments in information, eco-friendly technologies and R&D networks on a European – Asia basis are essential.
Vredespark - Park Meerland - Genderpark - Update 2009-2015
Eindhoven is “Place to be”
Global Network of Eindhoven PeaceGardens
Brainport – Creating the Industries of the Future
Cornerstone of the Dutch economy
Sensors in Medicine 2017
A short introduction to the objective, program and speakers at the 5th Annual Sensors in Mediicne Conference
Innovation and value creation in the health sector
Norway Health Tech is a non-profit organization established in 2009 that represents over 200 members across the healthcare value chain in Norway. It aims to address all areas of human health through collaboration between healthcare industry, providers, researchers, and government. Key challenges in healthcare like aging populations and chronic diseases are driving needs for new healthcare products and solutions. Norway has strong assets in this area like research institutions, healthcare systems, and a concentration of activity in the Oslo region that can support innovation.
Brochure | Case Reports Conference 2018 | London,UK | May 28-29
Euroscicon Ltd proudly presents the “8th International Conference on Clinical and Medical Case Reports, 2018” to be held on May 28-29, 2018 at London, UK.
This year’s theme is “Clinical and Medical Case Reports that pave way for an advanced healthcare”
Please visit the Conference website for more details : http://casereports.euroscicon.com/
Academic careers in Novo Nordisk, Lund, May 7 2014
Novo Nordisk is a global healthcare company with 90 years of experience in diabetes care, insulin, and injection devices. It has over 33,000 employees working across production sites, R&D facilities, and clinical development centers around the world. Novo Nordisk invests heavily in attracting and developing talent through various fellowship programs like STAR and LIFEPHARM. These programs provide postdoctoral research opportunities and aim to support the next generation of scientists through funding, networking events, and skills training. Novo Nordisk relies on attracting excellent talent globally to sustain its innovation and growth.
Triskelion instrumental analysis structure elucidation, v2
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
More Related Content
Similar to Triskelion@slideshare
P 135 asthma and copd
This document provides information about an upcoming conference on asthma and COPD to be held on April 13-14, 2015 in London. It lists key speakers from academic institutions and pharmaceutical companies that will discuss topics such as new therapeutics, personalised treatment approaches, viral exacerbations, and biomarkers. An interactive workshop on functional respiratory imaging is also advertised to take place on April 15. The document provides an agenda with session details and encourages registration by certain dates to receive discounts.
SMi Group's RNA Therapeutics 2019 conference
This document provides information about the 10th Annual Conference on RNA Therapeutics taking place on February 20-21, 2019 in London. It outlines the chairs, guest speakers, and key speakers at the conference, as well as featured highlights and topics to be discussed. Some of the topics to be covered include the clinical progress of spherical nucleic acids with Exicure, Sanofi's strategies for oligonucleotide delivery, ProQR's plans for oligonucleotide supply, and the development of self-amplifying mRNA vaccines at GSK. The document provides an agenda and schedule for the two-day conference.
SMi Group's Superbugs & Superdrugs 2016 conference
This document provides information on two pre-conference workshops at the "Superbugs & Superdrugs" conference on combating antimicrobial resistance.
The first workshop discusses rapid diagnostic tools for infectious diseases, focusing on tracking emerging infections, state-of-the-art diagnostic methods, mobile applications, and challenges in diagnosis.
The second workshop examines how antimicrobial copper touch surfaces can improve patient outcomes and reduce costs by lowering healthcare-associated infections and antimicrobial resistance. It will evaluate the evidence supporting copper's use and discuss cost-benefit analysis and practical implementation.
P-163 Superbugs & Superdrugs
This document provides information on two pre-conference workshops at the "Superbugs & Superdrugs" conference on combating antimicrobial resistance.
The first workshop discusses rapid diagnostic tools for infectious diseases, focusing on tracking emerging infections, state-of-the-art diagnostic methods, mobile applications, and challenges in diagnosis.
The second workshop examines making materials like copper touch surfaces in healthcare settings to improve patient outcomes and reduce costs by lowering infection rates and antimicrobial resistance. It will evaluate the evidence for copper's antimicrobial efficacy and cost-benefit analysis.
2015 03-11 Opening EATRIS Finland, Helsinki
View how to enable personalzied healthcare through integrated technolgies, with great challenges to bridge the innovation gaps in biomarkers.
Epistem holdings plc (ehp) product pipeline analysis
Companyprofilesandconferences.com glad to promote a new report on "Epistem Holdings Plc (EHP) - Product Pipeline Analysis" which is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products also provides key information about the company, its major products and brands.
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Onorach Clinical is a clinical research organization headquartered in Dundee, Scotland that manages clinical trials from Phase I-IV. It has locations also in Latvia and provides services to pharmaceutical and medical device companies of all sizes. Onorach focuses on innovative electronic solutions to improve clinical trial quality and efficiency. It has expertise across many therapeutic areas including oncology, diabetes, vaccines, and more. Onorach aims to deliver high-quality, cost-effective clinical trial services through strategic partnerships.
2014 11-26 EATRIS biomarkers platform meeting, Amsterdam, Organising technolo...
Outlining the proces and lessons learned in organising the technological infrastructure at the Radboud university medical center, to shape the Radboudumc Technology Centers, supporting our mission in enabling personalized healthcare.
Europe's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdf
In this edition, 'Europe's Pioneering Leaders Shaping the Future of Healthcare - Edition 2', we explore the inspiring journeys of these remarkable individuals. From leveraging latest technologies to building collaboration among stakeholders, their initiatives are focused on improving patient outcomes and ensuring equitable access to healthcare services for all.
SMi Group's 8th annual COPD 2016 conference
This document advertises and provides information about the 8th Annual Conference on Chronic Obstructive Pulmonary Disease (COPD) to be held in London on October 19-20, 2016. It announces early registration discounts and details the conference agenda, speakers, and sessions on topics related to COPD drug development, treatment strategies, and predictive modeling. Attendees in 2015 represented pharmaceutical companies, consultancies, and academia from Europe, the UK, and the US. The conference organizers encourage sponsorship and exhibition opportunities to promote services and products to attendees.
Insights in Life Sciences (ilS) Provides Access to Global Life Sciences Experts
Insights in Life Sciences (ilS) provides guidance in project definition by ilS professionals; Life Sciences Expert screening via ilS platform (ilS NetworkSM); Telephone call scheduling via ilS NetworkSM; Telephone interviews and final reports (ilS ReportsSM) via ilS platform
SplunkLive! Stockholm 2017 - Norsk Helsenett Customer Presentation
Norsk Helsenett's customer presentation at SplunkLive! Stockholm, presented by Håkon Grimstad, CEO.
Attendees of SplunkLive! Stockholm learnt how more than 13,000 enterprises, government agencies, universities and service providers in over 110 countries use Splunk software to deepen business and customer understanding, mitigate cybersecurity risk, prevent fraud, improve service performance and reduce cost.
Become a Medicines Discovery Catapult Partner - Glasgow
We enable UK life science companies to develop their drug discovery projects. And through networks of expert labs and CROs our Virtual R&D team can access and provide:
> industrially rigorous advice in drug discovery
> clinical and commercial insight
> expertise in delivery and project management
If you are an SME with a drug discovery project, or a CRO with expertise to provide, attend this event and find out how we can help you.
ExL Pharma's European Medical Science Liaison Conference Brochure, October, L...
Scientific Advisors (SAs), Medical Advisors (MAs) and Medical Science Liaisons (MSLs) play a critical function within Medical Affairs departments of pharmaceutical, biotech and medical device companies. These typically highly educated and experienced professionals evaluate, critique and communicate comprehensive scientific information related to a company’s products. While differences in job titles, backgrounds and day-to-day activities can vary across companies and regions, MSLs and advisors are critical to improving understanding amongst internal departments and supporting product awareness across the broader medical community. They are credible peers on whom thought leaders can rely for current, objective and thorough information about disease states and treatments. They assist clinical teams, often support and help train the sales force, and develop relationships with key opinion leaders, among other activities. MSLs/Advisors are key players in the achievement of corporate business objectives in the fiercely competitive European marketplace.
ExL Pharma’s MSL Best Practices conference has a long and established history in the United States, with seven highly successful and valuable MSL events taking place throughout America over a five year period. These conferences continue to attract more and more industry professionals, and have solidified ExL Pharma as a leader in the provision of relevant and practical information for Medical Affairs professionals. From the US-based events, a need was assessed for a similar conference to take place in Europe. Thus, the European MSL & Medical/Scientific Advisor Best Practices conference was born.
We are excited to offer this unique opportunity in Europe for MSLs and Advisors throughout the industry to gather to share successful strategies for both field-based and office-based activities. Through the provision of case studies and educational presentations led by experienced industry professionals, ample networking time and interactive sessions, MSLs and Advisors are sure to gain take-home approaches for providing maximum value to key opinion leaders, the company and the industry as a whole.
We look forward to greeting you in London!
Cv Aloys Eng 2009
Since the early days of his career, he had strong conviction for holistic care en
innovation. Believing that the aim of society must be the self-fulfillment of each
individual, by promoting education at all levels.
Support for scientists and researchers, technology transfer, investments in information, eco-friendly technologies and R&D networks on a European – Asia basis are essential.
Vredespark - Park Meerland - Genderpark - Update 2009-2015
Eindhoven is “Place to be”
Global Network of Eindhoven PeaceGardens
Brainport – Creating the Industries of the Future
Cornerstone of the Dutch economy
Sensors in Medicine 2017
A short introduction to the objective, program and speakers at the 5th Annual Sensors in Mediicne Conference
Innovation and value creation in the health sector
Norway Health Tech is a non-profit organization established in 2009 that represents over 200 members across the healthcare value chain in Norway. It aims to address all areas of human health through collaboration between healthcare industry, providers, researchers, and government. Key challenges in healthcare like aging populations and chronic diseases are driving needs for new healthcare products and solutions. Norway has strong assets in this area like research institutions, healthcare systems, and a concentration of activity in the Oslo region that can support innovation.
Brochure | Case Reports Conference 2018 | London,UK | May 28-29
Euroscicon Ltd proudly presents the “8th International Conference on Clinical and Medical Case Reports, 2018” to be held on May 28-29, 2018 at London, UK.
This year’s theme is “Clinical and Medical Case Reports that pave way for an advanced healthcare”
Please visit the Conference website for more details : http://casereports.euroscicon.com/
Academic careers in Novo Nordisk, Lund, May 7 2014
Novo Nordisk is a global healthcare company with 90 years of experience in diabetes care, insulin, and injection devices. It has over 33,000 employees working across production sites, R&D facilities, and clinical development centers around the world. Novo Nordisk invests heavily in attracting and developing talent through various fellowship programs like STAR and LIFEPHARM. These programs provide postdoctoral research opportunities and aim to support the next generation of scientists through funding, networking events, and skills training. Novo Nordisk relies on attracting excellent talent globally to sustain its innovation and growth.
Similar to Triskelion@slideshare (20)
SMi Group's Superbugs & Superdrugs 2016 conference
SMi Group's Superbugs & Superdrugs 2016 conference
Epistem holdings plc (ehp) product pipeline analysis
Epistem holdings plc (ehp) product pipeline analysis
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
2014 11-26 EATRIS biomarkers platform meeting, Amsterdam, Organising technolo...
2014 11-26 EATRIS biomarkers platform meeting, Amsterdam, Organising technolo...
Europe's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdf
Europe's Pioneering Leaders Shaping the Future of Healthcare- Edition 2.pdf
Insights in Life Sciences (ilS) Provides Access to Global Life Sciences Experts
Insights in Life Sciences (ilS) Provides Access to Global Life Sciences Experts
SplunkLive! Stockholm 2017 - Norsk Helsenett Customer Presentation
SplunkLive! Stockholm 2017 - Norsk Helsenett Customer Presentation
Become a Medicines Discovery Catapult Partner - Glasgow
Become a Medicines Discovery Catapult Partner - Glasgow
ExL Pharma's European Medical Science Liaison Conference Brochure, October, L...
ExL Pharma's European Medical Science Liaison Conference Brochure, October, L...
Innovation and value creation in the health sector
Innovation and value creation in the health sector
Brochure | Case Reports Conference 2018 | London,UK | May 28-29
Brochure | Case Reports Conference 2018 | London,UK | May 28-29
Academic careers in Novo Nordisk, Lund, May 7 2014
Academic careers in Novo Nordisk, Lund, May 7 2014
More from Paul Stoffels
Triskelion instrumental analysis structure elucidation, v2
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Triskelion instrumental analysis authenticity, v2
This document discusses using LC-MS methods for authenticity testing of animal species in food products. It provides examples of using collagen and milk/blood proteins to identify species through analysis of peptide sequences. Specific peptides are identified that can distinguish between cow, goat, sheep and other species milk. The methods allow detection of minority species proteins in mixtures. Protein isoforms can also be differentiated. Quick identification of blood proteins from different species like rat, mouse, bovine etc is demonstrated.
Pharma Gastro Intestinal Research, Outsourcing your R&D
This document provides a summary of 3 peer-reviewed publications on the topic of TIM systems:
1. A 2003 PhD thesis from the Swedish University of Agricultural Sciences on vitamin B12, folate, and folate binding proteins in dairy products.
2. A 2001 PhD thesis from Utrecht University on the mutagenic and antimutagenic activity of food compounds using an in vitro gastrointestinal model.
3. A 2010 PhD thesis from Maastricht University on bioactive compounds in whole grain wheat.
More from Paul Stoffels (6)
Triskelion instrumental analysis structure elucidation, v2
Triskelion instrumental analysis structure elucidation, v2
Triskelion instrumental analysis protein lc-ms, v2
Triskelion instrumental analysis protein lc-ms, v2
Triskelion instrumental analysis customized analysis, v2
Triskelion instrumental analysis customized analysis, v2
Pharma Gastro Intestinal Research, Outsourcing your R&D
Pharma Gastro Intestinal Research, Outsourcing your R&D
Recently uploaded
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
This quiz was conducted as a promotional event for the 2024 Annual Meet of Kerala Chapter of API.
More than 20 participants took part everyday !
DECLARATION OF HELSINKI - History and principles
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
How to choose the best dermatologists in Indore.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
une 2024 Oncology Cartoons By Dr Kanhu Charan Patro
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
This document outlines policies and procedures for handling narcotic and controlled drugs in NABH accredited hospitals.
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Pharmacology of 5-hydroxytryptamine and Antagonist
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Ketone bodies and metabolism-biochemistry
This slide consists of all the topics of ketone . This can be used for exam purpose for writing about Diabetic keto acidosis etc . Thank you
Recently uploaded (20)
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Triskelion@slideshare
- 1. • As of the 21st of March 2016 our Company changed his “brand” name and logo • The logo’s and branding will be changed soon. Below you will find our new re-presentation and logo • Our new website can be found on www.triskelion.nl New Company Branding
- 2. Triskelion and Immunology Short intro, portfolio focus 2016
- 3. • Contract Research Organisation • Commercial company, separated from TNO institute in 2011 • 220 employed scientists • All facilities, 1 central location in The Netherlands TNO Triskelion BV 3
- 4. 4 Triskelion Toxicology Analytical Services Regulatory Services & Risk Evaluation ADME/DMPK Pharmacology & Immunology TNO Triskelion – Markets and Expertise
- 6. 6 BREAKTHROUGH OF THE YEAR
- 7. CANCER IMMUNOTHERAPY FOCUS AND DEVELOPMENT XENOGRAFT MODELS IMMUNE DEFICIENT MOUSE HUMAN CELL TUMOR FULLY HUMANIZED MODELS FULLY COMPETENT HUMAN IMMUNE SYSTEM FULLY COMPETENT MOUSE IMMUNE SYSTEM MOUSE CELL TUMOR HUMAN TUMOR SYNGENEIC MODELS HUMAN PBMC SEB_IL-2 ASSAY HUMAN IN VITRO MODEL
- 8. 8 Contact & Information Follow us on linkedin Visit our website (will be updated in march 2016) http://www.tnotriskelion.com/pharma Or call me at +31652803578 or mail paul.stoffels@tno.triskelion.nl This presentation is a limited version of a full slide deck with more details we are able to share on our expertise areas Contact us if you wish to discuss your topic of interest